About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
Speaker of the House Nancy Pelosi recently unveiled a plan that would fundamentally change how patients access medicines in the United States. Her plan threatens our country’s global leadership in developing new treatments and cures, and it would force patients to face the uncertainty of a health care system where the government sets prices for medicines and imports foreign determinations of the value of medicines. This plan is the wrong approach for Americans, the U.S. health care system, American innovation and the U.S. economy. Download this slide deck to learn more about the implications of Speaker Pelosi’s drug pricing plan.
Implications of Speaker Pelosi's Drug Pricing Plan image
Fact Sheet
Report
Implications of Speaker Pelosi's Drug Pricing Plan
Implications of Speaker Pelosi's Drug Pricing Plan image